• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Johnson & Johnson Stock May Take a While to Rebound From Talc Hit

Shares have fallen hard, despite the company's vehement scientific and legal defense.
By KEVIN CURRAN Dec 23, 2018 | 02:30 PM EST
Stocks quotes in this article: JNJ

Johnson & Johnson (JNJ) may have trouble beautifying its share price for a time, even amidst a vehement scientific and legal defense.

The shares have fallen precipitously, from a high near $150 per share just before a Reuters report alleged that the company knew about asbestos in its talc powder for decades, to a close of $128.09 on Friday.

"The truth is that many parents would rather chew glass than use Johnson & Johnson products on their children [right now]," Eric Schiffer, CEO of the Patriarch Organization and Chairman of Reputation Management Consultants, told Real Money. "That reputation applies beyond talc too."

Schiffer explained that even as the company defends itself on scientific and legal grounds, the ubiquitous headlines have taken their toll to a far larger degree than the 0.3% of sales talc represents for the New Jersey-based healthcare conglomerate.

To be sure, the company has shown an ability to defend itself and come back from prior bad press, as it did in 2010 in response to bad headlines related to a Tylenol recall. Shares have doubled in value since that time.

Further, CEO Alex Gorsky made a personal appeal Monday afternoon on the company's website in a bid to tamp down the most recent controversy, explaining that reports of product safety lapses are defamatory.

"I want you to hear it directly from me: We know our talc is safe. In fact, for over 100 years Johnson & Johnson has known the talc in our baby powder is the purest, safest, pharmaceutical-grade talc on earth," Gorsky says in the video.

Gorsky's defense was laid out broadly, with the company outlining omissions and misstatements in the Reuters report and scientific studies vindicating the company.

"Thousands of independent tests by regulators and the world's leading labs prove our baby powder has never contained asbestos," the statement added, linking to an entire company website outlining a defense of its talc products.

Order in the Court of Public Opinion

Unfortunately for Johnson & Johnson, the company's defense, so far, has been outshone by a recent court case to the tune of a $4.7 billion decision. Johnson & Johnson indicated it will appeal the ruling.

"The litigation has increased substantially and I expect an avalanche of litigation still coming," Schiffer said. "The company is going to need to wage a war in the courtroom to maintain consumer trust."

Settlements in these type of situations can lessen hits to a company's cash pile, but may not placate many consumers. Instead, Schiffer suggested the company will need a strongly exculpatory judgment in its favor to restore its currently tarnished public image.

Schiffer conceded that Johnson & Johnson's recently announced $5 billion stock buyback goes to show that the company remains confident in its ability to fight these cases to do just that, adding that it should buoy many shareholders through this rough patch.

Nonetheless, the dust, or talcum powder in this case, will need to settle before many stock buyers and shoppers feel comfortable with Johnson & Johnson.

"Talc does not seem to be an issue that is going to resolve quickly for JNJ and we would expect shares to trade at a lower multiple pending further clarity on the company's exposure to this issue," J.P. Morgan analyst Chris Schott wrote in a note to clients following the reports. "[That could take] an extended period of time."

So, as Jim Cramer has suggested, maybe investors should likewise be a bit cautious for a more concrete signal before moving more dry powder into JNJ stock, as the reliable dividend stock is still dealing with these negative headlines.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities.

Action Alerts PLUS, which Cramer manages as a charitable trust, is long JNJ.

TAGS: Litigation | Earnings | Investing | Stocks

More from Stocks

AMC Is a High Risk, High Reward Play

Timothy Collins
Jan 22, 2021 2:15 PM EST

Short and sweet: This is based on the high running emotions of the markets. There's little to it beyond that.

GoodRx Needs a Shot in the Arm to Improve Its Outlook

Bruce Kamich
Jan 22, 2021 2:03 PM EST

IPOs in recent months have done extremely well -- not so GDRX.

GameStop and the Dangerous Game of Gamma Squeezes

Timothy Collins
Jan 22, 2021 1:26 PM EST

What happened after Citron Research posted a video about GameStop is very troubling.

Stocks Are Well Off Early Lows, but There's Still Quite a Bit of Weakness

James "Rev Shark" DePorre
Jan 22, 2021 1:18 PM EST

There is still strong interest in stock picking which is the most positive thing about this market.

Jim Cramer: The Market Now Acts Like a Market of Stocks Than a Bushel or a Peck

Jim Cramer
Jan 22, 2021 12:52 PM EST

There was a period before the time of commoditization where individual elan and corporate dominance meant something. And that's back.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    I'll discuss price targets in my Saturday column.
  • 07:54 AM EST GARY BERMAN

    Friday Morning Fibocall for 1/22/2021

    SPX (Long-Term View) The 1/21/21 NEW high @ 3861...
  • 11:16 AM EST CHRIS VERSACE

    Worst Stocks to Buy for the Biden Presidency

    Biden's take on the minimum wage, likely moves on ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login